*Storage:
*Shipping:
CC-115 is an inhibitor ofmTOR andDNA-PK with IC50 of 21 and 13 nM respectively.
4.5
*For Research Use Only !
Change View
Size | Price | US Stock | Global Stock | In Stock |
5mg | ł§ó¶ÊÊ | Inquiry | Inquiry | |
10mg | łÿò¶ÊÊ | Inquiry | Inquiry | |
25mg | łîÿ¶ÊÊ | Inquiry | Inquiry | |
50mg | łÇÿʶÊÊ | Inquiry | Inquiry | |
100mg | łË§Ê¶ÊÊ | Inquiry | Inquiry |
US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks
ł§ó¶ÊÊ
łÿò¶ÊÊ
łîÿ¶ÊÊ
łÇÿʶÊÊ
łË§Ê¶ÊÊ
In Stock
- +
US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks
Search for reports by entering the product batch number.
Batch number can be found on the product's label following the word 'Batch'.
Search for reports by entering the product batch number.
Batch number can be found on the product's label following the word 'Batch'.
Search for reports by entering the product batch number.
Batch number can be found on the product's label following the word 'Batch'.
Search for reports by entering the product batch number.
Batch number can be found on the product's label following the word 'Batch'.
Search for reports by entering the product batch number.
Batch number can be found on the product's label following the word 'Batch'.
CAS No. : | 1228013-15-7 |
Formula : | C16H16N8O |
M.W : | 336.35 |
SMILES Code : | O=C1CN=C2C(N1CC)=NC(C3=C(C)N=C(C4=NN=CN4)C=C3)=CN2 |
MDL No. : | MFCD29036965 |
InChI Key : | GMYLVKUGJMYTFB-UHFFFAOYSA-N |
Pubchem ID : | 58298318 |
GHS Pictogram: | ![]() |
Signal Word: | Warning |
Hazard Statements: | H302-H315-H319-H335 |
Precautionary Statements: | P261-P305+P351+P338 |
Target |
|
In Vitro:
Cell Line
| Concentration | Treated Time | Description | Reference |
Multiple myeloma cells | 1.5 nM to 10 µM | 72 h | CC-115 showed dose-dependent growth inhibition in multiple myeloma cells, and its effect was superior to the specific TORK inhibitor CC-223. | PMC9892823 |
HCT 116 cells | 0.1 µM to 3.5 µM | 4 h | CC-115 induced a dose-dependent increase in NMD transcripts in HCT 116 cells, indicating inhibition of SMG1-mediated NMD. | PMC9892823 |
CAL33 | 1 µM | 24 h | CC-115 + IR treatment led to an elevation in G2/M arrest, increased cell death, and a synergistic reduction in cell proliferation, though the effect was notably lower compared to the AZD7648 + IR- treated group. | PMC10887161 |
UM-SCC-47 | 1 µM | 24 h | CC-115 + IR treatment led to an elevation in G2/M arrest, increased cell death, and a synergistic reduction in cell proliferation, though the effect was notably lower compared to the AZD7648 + IR- treated group. | PMC10887161 |
LNCaP-AR | 1 μM | 24 h | reduced invasion and migration of CRPC cells | PMC6744969 |
C4-2B | 1 μM | 24 h | reduced invasion and migration of CRPC cells | PMC6744969 |
LNCaP-AR-enza-res | 1 μM | 24 h | reduced invasion and migration of enzalutamide-resistant CRPC cells | PMC6744969 |
C4-2 | 0–25 μM | 6 days | Assessment of CC-115 in hormone-sensitive and castration-resistant prostate cancer models showed that CC-115 reduced cell viability in a dose-dependent manner and induced apoptosis. | PMC6744985 |
22Rv1 | 0–25 μM | 6 days | Assessment of CC-115 in hormone-sensitive and castration-resistant prostate cancer models showed that CC-115 reduced cell viability in a dose-dependent manner and induced apoptosis. | PMC6744985 |
Healthy donor skin fibroblasts (SBLF7) | 0.1–25 μM | 48 h | To study the effect of CC-115 on cell death, results showed that cell death increased linearly with increasing concentration of CC-115. | PMC7730287 |
Melanoma cells (ARPA) | 0.1–25 μM | 48 h | To study the effect of CC-115 on cell death, results showed that melanoma cells were more sensitive to CC-115, with cell death reaching saturation at higher concentrations. | PMC7730287 |
Melanoma cells (HV18MK) | 0.1–25 μM | 48 h | To study the effect of CC-115 on cell death, results showed that melanoma cells were more sensitive to CC-115, with cell death reaching saturation at higher concentrations. | PMC7730287 |
LOU-NH91 | 25.10 μM | 72 h | Assessed the IC50 value of CC-115 on LOU-NH91 cells, showing synergistic effects with carboplatin | PMC9452486 |
H596 | 0.68 μM | 72 h | Assessed the IC50 value of CC-115 on H596 cells, showing synergistic effects with carboplatin | PMC9452486 |
H1975 | 0.31 μM | 72 h | Assessed the IC50 value of CC-115 on H1975 cells, showing synergistic effects with carboplatin | PMC9452486 |
TM00244 | 0.43 μM | 72 h | Assessed the IC50 value of CC-115 on TM00244 cells, showing synergistic effects with carboplatin | PMC9452486 |
H226 | 0.95 μM | 72 h | Assessed the IC50 value of CC-115 on H226 cells, showing synergistic effects with carboplatin | PMC9452486 |
Calu-1 | 1.38 μM | 72 h | Assessed the IC50 value of CC-115 on Calu-1 cells, showing synergistic effects with carboplatin | PMC9452486 |
Atmfl/fl; LSL-KrasG12D/+; Ptf1aCre/+ (AKC) cells | 30 nM | 6 h | To evaluate the effect of CC-115 on DNA replication dynamics | PMC7948173 |
ATM+/Δ MIA PaCa-2 cells | 30 nM | 48 h | To evaluate the synergistic effect of CC-115 in combination with PARPi and ATRi | PMC7948173 |
LOU-NH91 | 0.2 μM | 72 h | CC-115 in combination with carboplatin showed synergistic effects in LOU-NH91 cells, significantly inhibiting cell viability. | PMC9452486 |
Calu-1 | 0.4 μM | 72 h | CC-115 in combination with carboplatin showed synergistic effects in Calu-1 cells, significantly inhibiting cell viability. | PMC9452486 |
H226 | 0.4 μM | 72 h | CC-115 in combination with carboplatin showed synergistic effects in H226 cells, significantly inhibiting cell viability. | PMC9452486 |
In Vivo:
Species
| Animal Model
| Administration | Dosage | Frequency | Description | Reference |
Mice | Multiple myeloma xenograft model | Oral | 5 mg/kg | Once daily until day 36 | CC-115 showed significant antitumor activity in the multiple myeloma xenograft model, with a significant reduction in tumor volume and good tolerability. | PMC9892823 |
CB17-SCID mice | LNCaP-AR xenograft model | oral | 2 mg/kg | 5 times per week for 6 weeks | significantly delayed tumor growth | PMC6744969 |
CB17 SCID mice | Castration-resistant prostate cancer model | Oral | 2 mg/kg | Once daily for 39 days | Evaluation of the tumor growth inhibitory effects of CC-115 in combination with Enzalutamide in castration-resistant prostate cancer models showed that the combination treatment significantly increased tumor doubling time and improved survival rates. | PMC6744985 |
mice | LUSC PDX models | oral gavage and I.P. injection | 1 mg/kg | once weekly for four weeks | Evaluated the antitumor effect of CC-115 in combination with carboplatin and paclitaxel on LUSC PDX models, showing significant tumor growth inhibition and prolonged survival | PMC9452486 |
Mice | Subcutaneous tumor model | Intraperitoneal injection | 2.5 mg/kg | Once daily for 17 days | To evaluate the inhibitory effect of CC-115 in combination with PARPi and ATRi on the growth of ATM-deficient PDAC tumors | PMC7948173 |
Mice | LUSC patient-derived xenograft models | Oral gavage (CC-115), Intraperitoneal injection (carboplatin and paclitaxel) | 1 mg/kg | Once weekly (carboplatin and paclitaxel), daily (CC-115), for four weeks | CC-115 in combination with carboplatin and paclitaxel significantly inhibited tumor growth and extended survival in mice. | PMC9452486 |
Clinical Trial:
NCT Number | Conditions | Phases | Recruitment | Completion Date | Locations |
NCT01353625 | Glioblastoma Multiforme|Squamo... More >>us Cell Carcinoma of Head and Neck|Prostate Cancer|Ewing's Osteosarcoma|Chronic Lymphocytic Leukemia|Neoplasm Metastasis Less << | PHASE1 | COMPLETED | 2021-03-12 | Cedars-Sinai Medical Center, L... More >>os Angeles, California, 90048, United States|UCLA, Los Angeles, California, 90095, United States|University of California, San Francisco Comprehensive Cancer Center and Cancer Research Institiute, San Francisco, California, 94115, United States|Moffitt Cancer Center, Tampa, Florida, 33612, United States|University of Michigan Comprehensive Cancer Center, Ann Arbor, Michigan, 48109, United States|Henry Ford Medical Center - New Center One, Detroit, Michigan, 48202, United States|Memorial Sloan-Kettering Cancer Center, New York, New York, 10021, United States|Sarah Cannon Research Institute Drug Development Unit, Nashville, Tennessee, 37203, United States|Mary Crowley Medical Research Center, Dallas, Texas, 75201, United States|The University of Texas MD Anderson Cancer Center, Houston, Texas, 77303, United States|Gustave Roussy, Villejuif Cedex, 94805, France|Uniklinik Koln, Koeln, 50937, Germany|Universitatsklinikum Wurzburg, Würzburg, 97070, Germany|Hospital Val d'Hebron, Barcelona, 08035, Spain|Hospital Universitario Madrid Sanchinarro, Madrid, 28050, Spain|Hospital de Donosti, San Sebastián (Guipuzcoa), 20014, Spain|Hospital Virgen del Rocio, Sevilla, 41013, Spain Less << |
Bio Calculators | ||||
Preparing Stock Solutions | ![]() | 1mg | 5mg | 10mg |
1 mM 5 mM 10 mM | 2.97mL 0.59mL 0.30mL | 14.87mL 2.97mL 1.49mL | 29.73mL 5.95mL 2.97mL |
Tags: CC-115 | CC115 | CC 115 | DNA-PK | mTOR | DNA-dependent protein kinase | Mammalian target of Rapamycin | 1228013-15-7
Precautionary Statements-General | |
Code | Phrase |
P101 | If medical advice is needed,have product container or label at hand. |
P102 | Keep out of reach of children. |
P103 | Read label before use |
Prevention | |
Code | Phrase |
P201 | Obtain special instructions before use. |
P202 | Do not handle until all safety precautions have been read and understood. |
P210 | Keep away from heat/sparks/open flames/hot surfaces. - No smoking. |
P211 | Do not spray on an open flame or other ignition source. |
P220 | Keep/Store away from clothing/combustible materials. |
P221 | Take any precaution to avoid mixing with combustibles |
P222 | Do not allow contact with air. |
P223 | Keep away from any possible contact with water, because of violent reaction and possible flash fire. |
P230 | Keep wetted |
P231 | Handle under inert gas. |
P232 | Protect from moisture. |
P233 | Keep container tightly closed. |
P234 | Keep only in original container. |
P235 | Keep cool |
P240 | Ground/bond container and receiving equipment. |
P241 | Use explosion-proof electrical/ventilating/lighting/equipment. |
P242 | Use only non-sparking tools. |
P243 | Take precautionary measures against static discharge. |
P244 | Keep reduction valves free from grease and oil. |
P250 | Do not subject to grinding/shock/friction. |
P251 | Pressurized container: Do not pierce or burn, even after use. |
P260 | Do not breathe dust/fume/gas/mist/vapours/spray. |
P261 | Avoid breathing dust/fume/gas/mist/vapours/spray. |
P262 | Do not get in eyes, on skin, or on clothing. |
P263 | Avoid contact during pregnancy/while nursing. |
P264 | Wash hands thoroughly after handling. |
P265 | Wash skin thouroughly after handling. |
P270 | Do not eat, drink or smoke when using this product. |
P271 | Use only outdoors or in a well-ventilated area. |
P272 | Contaminated work clothing should not be allowed out of the workplace. |
P273 | Avoid release to the environment. |
P280 | Wear protective gloves/protective clothing/eye protection/face protection. |
P281 | Use personal protective equipment as required. |
P282 | Wear cold insulating gloves/face shield/eye protection. |
P283 | Wear fire/flame resistant/retardant clothing. |
P284 | Wear respiratory protection. |
P285 | In case of inadequate ventilation wear respiratory protection. |
P231 + P232 | Handle under inert gas. Protect from moisture. |
P235 + P410 | Keep cool. Protect from sunlight. |
Response | |
Code | Phrase |
P301 | IF SWALLOWED: |
P304 | IF INHALED: |
P305 | IF IN EYES: |
P306 | IF ON CLOTHING: |
P307 | IF exposed: |
P308 | IF exposed or concerned: |
P309 | IF exposed or if you feel unwell: |
P310 | Immediately call a POISON CENTER or doctor/physician. |
P311 | Call a POISON CENTER or doctor/physician. |
P312 | Call a POISON CENTER or doctor/physician if you feel unwell. |
P313 | Get medical advice/attention. |
P314 | Get medical advice/attention if you feel unwell. |
P315 | Get immediate medical advice/attention. |
P320 | |
P302 + P352 | IF ON SKIN: wash with plenty of soap and water. |
P321 | |
P322 | |
P330 | Rinse mouth. |
P331 | Do NOT induce vomiting. |
P332 | IF SKIN irritation occurs: |
P333 | If skin irritation or rash occurs: |
P334 | Immerse in cool water/wrap n wet bandages. |
P335 | Brush off loose particles from skin. |
P336 | Thaw frosted parts with lukewarm water. Do not rub affected area. |
P337 | If eye irritation persists: |
P338 | Remove contact lenses, if present and easy to do. Continue rinsing. |
P340 | Remove victim to fresh air and keep at rest in a position comfortable for breathing. |
P341 | If breathing is difficult, remove victim to fresh air and keep at rest in a position comfortable for breathing. |
P342 | If experiencing respiratory symptoms: |
P350 | Gently wash with plenty of soap and water. |
P351 | Rinse cautiously with water for several minutes. |
P352 | Wash with plenty of soap and water. |
P353 | Rinse skin with water/shower. |
P360 | Rinse immediately contaminated clothing and skin with plenty of water before removing clothes. |
P361 | Remove/Take off immediately all contaminated clothing. |
P362 | Take off contaminated clothing and wash before reuse. |
P363 | Wash contaminated clothing before reuse. |
P370 | In case of fire: |
P371 | In case of major fire and large quantities: |
P372 | Explosion risk in case of fire. |
P373 | DO NOT fight fire when fire reaches explosives. |
P374 | Fight fire with normal precautions from a reasonable distance. |
P376 | Stop leak if safe to do so. Oxidising gases (section 2.4) 1 |
P377 | Leaking gas fire: Do not extinguish, unless leak can be stopped safely. |
P378 | |
P380 | Evacuate area. |
P381 | Eliminate all ignition sources if safe to do so. |
P390 | Absorb spillage to prevent material damage. |
P391 | Collect spillage. Hazardous to the aquatic environment |
P301 + P310 | IF SWALLOWED: Immediately call a POISON CENTER or doctor/physician. |
P301 + P312 | IF SWALLOWED: call a POISON CENTER or doctor/physician IF you feel unwell. |
P301 + P330 + P331 | IF SWALLOWED: Rinse mouth. Do NOT induce vomiting. |
P302 + P334 | IF ON SKIN: Immerse in cool water/wrap in wet bandages. |
P302 + P350 | IF ON SKIN: Gently wash with plenty of soap and water. |
P303 + P361 + P353 | IF ON SKIN (or hair): Remove/Take off Immediately all contaminated clothing. Rinse SKIN with water/shower. |
P304 + P312 | IF INHALED: Call a POISON CENTER or doctor/physician if you feel unwell. |
P304 + P340 | IF INHALED: Remove victim to fresh air and Keep at rest in a position comfortable for breathing. |
P304 + P341 | IF INHALED: If breathing is difficult, remove victim to fresh air and keep at rest in a position comfortable for breathing. |
P305 + P351 + P338 | IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing. |
P306 + P360 | IF ON CLOTHING: Rinse Immediately contaminated CLOTHING and SKIN with plenty of water before removing clothes. |
P307 + P311 | IF exposed: call a POISON CENTER or doctor/physician. |
P308 + P313 | IF exposed or concerned: Get medical advice/attention. |
P309 + P311 | IF exposed or if you feel unwell: call a POISON CENTER or doctor/physician. |
P332 + P313 | IF SKIN irritation occurs: Get medical advice/attention. |
P333 + P313 | IF SKIN irritation or rash occurs: Get medical advice/attention. |
P335 + P334 | Brush off loose particles from skin. Immerse in cool water/wrap in wet bandages. |
P337 + P313 | IF eye irritation persists: Get medical advice/attention. |
P342 + P311 | IF experiencing respiratory symptoms: call a POISON CENTER or doctor/physician. |
P370 + P376 | In case of fire: Stop leak if safe to Do so. |
P370 + P378 | In case of fire: |
P370 + P380 | In case of fire: Evacuate area. |
P370 + P380 + P375 | In case of fire: Evacuate area. Fight fire remotely due to the risk of explosion. |
P371 + P380 + P375 | In case of major fire and large quantities: Evacuate area. Fight fire remotely due to the risk of explosion. |
Storage | |
Code | Phrase |
P401 | |
P402 | Store in a dry place. |
P403 | Store in a well-ventilated place. |
P404 | Store in a closed container. |
P405 | Store locked up. |
P406 | Store in corrosive resistant/ container with a resistant inner liner. |
P407 | Maintain air gap between stacks/pallets. |
P410 | Protect from sunlight. |
P411 | |
P412 | Do not expose to temperatures exceeding 50 oC/ 122 oF. |
P413 | |
P420 | Store away from other materials. |
P422 | |
P402 + P404 | Store in a dry place. Store in a closed container. |
P403 + P233 | Store in a well-ventilated place. Keep container tightly closed. |
P403 + P235 | Store in a well-ventilated place. Keep cool. |
P410 + P403 | Protect from sunlight. Store in a well-ventilated place. |
P410 + P412 | Protect from sunlight. Do not expose to temperatures exceeding 50 oC/122oF. |
P411 + P235 | Keep cool. |
Disposal | |
Code | Phrase |
P501 | Dispose of contents/container to ... |
P502 | Refer to manufacturer/supplier for information on recovery/recycling |
Physical hazards | |
Code | Phrase |
H200 | Unstable explosive |
H201 | Explosive; mass explosion hazard |
H202 | Explosive; severe projection hazard |
H203 | Explosive; fire, blast or projection hazard |
H204 | Fire or projection hazard |
H205 | May mass explode in fire |
H220 | Extremely flammable gas |
H221 | Flammable gas |
H222 | Extremely flammable aerosol |
H223 | Flammable aerosol |
H224 | Extremely flammable liquid and vapour |
H225 | Highly flammable liquid and vapour |
H226 | Flammable liquid and vapour |
H227 | Combustible liquid |
H228 | Flammable solid |
H229 | Pressurized container: may burst if heated |
H230 | May react explosively even in the absence of air |
H231 | May react explosively even in the absence of air at elevated pressure and/or temperature |
H240 | Heating may cause an explosion |
H241 | Heating may cause a fire or explosion |
H242 | Heating may cause a fire |
H250 | Catches fire spontaneously if exposed to air |
H251 | Self-heating; may catch fire |
H252 | Self-heating in large quantities; may catch fire |
H260 | In contact with water releases flammable gases which may ignite spontaneously |
H261 | In contact with water releases flammable gas |
H270 | May cause or intensify fire; oxidizer |
H271 | May cause fire or explosion; strong oxidizer |
H272 | May intensify fire; oxidizer |
H280 | Contains gas under pressure; may explode if heated |
H281 | Contains refrigerated gas; may cause cryogenic burns or injury |
H290 | May be corrosive to metals |
Health hazards | |
Code | Phrase |
H300 | Fatal if swallowed |
H301 | Toxic if swallowed |
H302 | Harmful if swallowed |
H303 | May be harmful if swallowed |
H304 | May be fatal if swallowed and enters airways |
H305 | May be harmful if swallowed and enters airways |
H310 | Fatal in contact with skin |
H311 | Toxic in contact with skin |
H312 | Harmful in contact with skin |
H313 | May be harmful in contact with skin |
H314 | Causes severe skin burns and eye damage |
H315 | Causes skin irritation |
H316 | Causes mild skin irritation |
H317 | May cause an allergic skin reaction |
H318 | Causes serious eye damage |
H319 | Causes serious eye irritation |
H320 | Causes eye irritation |
H330 | Fatal if inhaled |
H331 | Toxic if inhaled |
H332 | Harmful if inhaled |
H333 | May be harmful if inhaled |
H334 | May cause allergy or asthma symptoms or breathing difficulties if inhaled |
H335 | May cause respiratory irritation |
H336 | May cause drowsiness or dizziness |
H340 | May cause genetic defects |
H341 | Suspected of causing genetic defects |
H350 | May cause cancer |
H351 | Suspected of causing cancer |
H360 | May damage fertility or the unborn child |
H361 | Suspected of damaging fertility or the unborn child |
H361d | Suspected of damaging the unborn child |
H362 | May cause harm to breast-fed children |
H370 | Causes damage to organs |
H371 | May cause damage to organs |
H372 | Causes damage to organs through prolonged or repeated exposure |
H373 | May cause damage to organs through prolonged or repeated exposure |
Environmental hazards | |
Code | Phrase |
H400 | Very toxic to aquatic life |
H401 | Toxic to aquatic life |
H402 | Harmful to aquatic life |
H410 | Very toxic to aquatic life with long-lasting effects |
H411 | Toxic to aquatic life with long-lasting effects |
H412 | Harmful to aquatic life with long-lasting effects |
H413 | May cause long-lasting harmful effects to aquatic life |
H420 | Harms public health and the environment by destroying ozone in the upper atmosphere |
Sorry,this product has been discontinued.
Home
* Country/Region
* Quantity Required :
* Cat. No.:
* CAS No :
* Product Name :
* Additional Information :
Total Compounds: mg
The concentration of the dissolution solution you need to prepare is mg/mL